BALANCE SHEET
Concord Biotech Ltd.
BSE
Jun 13
2110.55
+50.30 (+ 2.44%)
Volume
4844
Prev. Close
2060.25
Open Price
2019.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
2109.70
+46.10 (+ 2.23%)
Volume
166986
Prev. Close
2063.60
Open Price
2010.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Balance Sheet
for the last 5 years.
|
ISIN No
|
INE338H01029
|
Market Cap. ( ₹ in Cr. )
|
22070.88
|
P/BV
|
13.88
|
Book Value ( ₹ )
|
152.02
|
|
BSE Code
|
543960
|
52 Week High/Low ( ₹ )
|
2664/1345
|
FV/ML
|
1/1
|
P/E(X)
|
59.39
|
|
NSE Code
|
CONCORDBIOEQ
|
Book Closure
|
29/06/2024
|
EPS ( ₹ )
|
35.52
|
Div Yield (%)
|
0.51
|
(₹ in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 |
| No. of Equity Shares (in Lacs) | 1046.16 | 1046.16 | 1046.16 |
| | | | |
| EQUITIES AND LIABILITIES | | | |
| SHAREHOLDER'S FUNDS | | | |
| Equity Share Capital | 10.46 | 10.46 | 10.46 |
| Total Share Capital | 10.46 | 10.46 | 10.46 |
| | | | |
| Reserves and Surplus | 1802.18 | 1514.79 | 1281.52 |
| Total Reserves and Surplus | 1802.18 | 1514.79 | 1281.52 |
| Total Shareholders Funds | 1812.65 | 1525.25 | 1291.98 |
| | | | |
| NON-CURRENT LIABILITIES | | | |
| Long Term Borrowings | 0.00 | 0.00 | 6.24 |
| Deferred Tax Liabilities [Net] | 34.02 | 28.06 | 23.44 |
| Other Long Term Liabilities | 0.63 | 1.89 | 0.16 |
| Long Term Provisions | 2.82 | 1.96 | 2.30 |
| Total Non-Current Liabilities | 37.47 | 31.91 | 32.14 |
| | | | |
| CURRENT LIABILITIES | | | |
| Short Term Borrowings | 0.38 | 6.23 | 25.00 |
| Trade Payables | 113.04 | 94.44 | 93.80 |
| Other Current Liabilities | 65.10 | 37.59 | 44.26 |
| Short Term Provisions | 5.54 | 3.90 | 27.48 |
| Total Current Liabilities | 184.06 | 142.16 | 190.53 |
| | | | |
| Total Capital And Liabilities | 2034.18 | 1699.32 | 1514.65 |
| | | | |
| ASSETS | | | |
| NON-CURRENT ASSETS | | | |
| Tangible Assets | 794.62 | 575.00 | 592.78 |
| Intangible Assets | 0.60 | 0.32 | 0.20 |
| Capital Work-In-Progress | 50.13 | 211.48 | 172.70 |
| Fixed Assets | 845.34 | 786.80 | 765.68 |
| Non-Current Investments | 18.65 | 0.67 | 0.79 |
| Other Non-Current Assets | 34.94 | 15.62 | 20.48 |
| Total Non-Current Assets | 898.94 | 803.08 | 786.95 |
| | | | |
| | | | |
| CURRENT ASSETS | | | |
| Current Investments | 316.54 | 243.70 | 136.93 |
| Inventories | 239.67 | 207.95 | 212.31 |
| Trade Receivables | 521.65 | 349.61 | 273.76 |
| Cash And Cash Equivalents | 1.18 | 47.02 | 43.45 |
| OtherCurrentAssets | 56.20 | 47.94 | 61.25 |
| Total Current Assets | 1135.24 | 896.23 | 727.70 |
| | | | |
| Total Assets | 2034.18 | 1699.32 | 1514.65 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | |
| Contingent Liabilities | 0.00 | 26.75 | 26.59 |
| | | | |
| BONUS DETAILS | | | |
| Bonus Equity Share Capital | 0.00 | 7.85 | 7.85 |
| | | | |
| NON-CURRENT INVESTMENTS | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.12 |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.67 | 0.67 |
| | | | |
| CURRENT INVESTMENTS | | | |
| Current Investments Quoted Market Value | 0.00 | 243.70 | 136.93 |